Management of Hemodialysis Access Infections

Seminars in Vascular Surgery

Volumn 17, Issue 1, 2004, Pages 40-44

  Ryan, Sean V ^a   Calligaro, Keith D ^a,b   Dougherty, Matthew J ^a  

^a PENNSYLVANIA HOSPITAL   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIMICROBIAL THERAPY; ARTERIOVENOUS FISTULA; AUTOGRAFT; CATHETER INFECTION; CENTRAL VENOUS CATHETER; COMORBIDITY; ENDOVASCULAR SURGERY; HEMODIALYSIS; HIGH RISK POPULATION; HUMAN; IMMUNE DEFICIENCY; INFECTION CONTROL; INFECTION RISK; NEPHROLOGY; NONHUMAN; PRIORITY JOURNAL; PROSTHESIS INFECTION; RADIOLOGIST; REVIEW; SHUNT INFECTION; STAPHYLOCOCCUS; SURGEON; SYMPTOM; TREATMENT OUTCOME; VASCULAR ACCESS;

EID: 1542741244     PISSN: 08957967     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semvascsurg.2003.11.004     Document Type: Article

References (42)

1. Nassar GM, Ayus JC: Infectious complications of the hemodialysis access. Kidney Int 60:1-13, 2001
2. Bonomo RA, Rice D, Whalen C, et al: Risk factors associated with permanent access-site infections in chronic hemodialysis patients. Infect Control Hosp Epidemiol 18:757-761, 1997
3. Causes of death. USRDS. United States Renal Data System. Am J Kidney Dis 30:S107-117, 1997
4. Padberg FT Jr, Lee BC, Curl GR: Hemoaccess site infection. Surg Gynecol Obstet 174:103-108, 1992
5. Mailloux LU, Bellucci AG, Wilkes BM, et al: Mortality in dialysis patients: analysis of the causes of death. Am J Kidney Dis 18:326-335, 1991
6. Sarnak MJ, Jaber BL: Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int 58:1758-1764, 2000
7. Gibson KD, Gillen DL, Caps MT, et al: Vascular access survival and incidence of revisions: a comparison of prosthetic grafts, simple autogenous fistulas, and venous transposition fistulas from the United States Renal Data System Dialysis Morbidity and Mortality Study. J Vasc Surg 34:694-700, 2001
8. Pesanti EL: Immunologic defects and vaccination in patients with chronic renal failure. Infect Dis Clin North Am 15:813-832, 2001
9. Kamata K, Okubo M: Derangement of humoral immune system in nondialyzed uremic patients. Jpn J Med 23:9-15, 1984
10. Girndt M, Sester M, Sester U, et al: Molecular aspects of T- and B-cell function in uremia. Kidney Int Suppl 78:S206-S211, 2001
11. Cohen G, Haag-Weber M, Horl WH: Immune dysfunction in uremia. Kidney Int Suppl 62:S79-S82, 1997
12. Jaber BL, Cendoroglo M, Balakrishnan VS, et al: Apoptosis of leukocytes: basic concepts and implications in uremia. Kidney Int Suppl 78:S197-S205, 2001
13. Kaplowitz LG, Comstock JA, Landwehr DM, et al: A prospective study of infections in hemodialysis patients: patient hygiene and other risk factors for infection. Infect Control Hosp Epidemiol 9:534-541, 1988
14. Pertosa G, Grandaliano G, Gesualdo L, et al: Clinical relevance of cytokine production in hemodialysis. Kidney Int Suppl 76:S104-S111, 2000
15. Girndt M, Lengler S, Kaul H, et al: Prospective crossover trial of the influence of vitamin E-coated dialyzer membranes on T-cell activation and cytokine induction. Am J Kidney Dis 35:95-104, 2000
16. Dobkin JF, Miller MH, Steigbigel NH: Septicemia in patients on chronic hemodialysis. Ann Intern Med 88:28-33, 1978
17. Kessler M, Hoen B, Mayeux D, et al: Bacteremia in patients on chronic hemodialysis. A multicenter prospective survey. Nephron 64:95-100, 1993
18. Marr KA, Kong L, Fowler VG, et al: Incidence and outcome of Staphylococcus aureus bacteremia in hemodialysis patients. Kidney Int 54:1684-1169, 1998
19. Piraino B: Staphylococcus aureus infections in dialysis patients: focus on prevention. ASAIO J 46:S13-S17, 2000
20. Lew SQ, Kaveh K: Dialysis access related infections. ASAIO J 46:S6-S12, 2000
21. Minga TE, Flanagan KH, Allon M: Clinical consequences of infected arteriovenous grafts in hemodialysis patients. Am J Kidney Dis 38:975-978, 2001
22. Ayus JC, Sheikh-Hamad D: Silent infection in clotted hemodialysis access grafts. J Am Soc Nephrol 9:1314-1317, 1998
23. Albers FJ: Clinical considerations in hemodialysis access infection. Adv Ren Replace Ther 3:208-217, 1996
24. Raju S: PTFE grafts for hemodialysis access. Techniques for insertion and management of complications. Ann Surg 206:666-673, 1987
25. Mohamed M, Habte-Gabr E, Mueller W: Infected arteriovenous hemodialysis graft presenting as left and right infective endocarditis. Am J Nephrol 15:521-523, 1995
26. Kaplowitz LG, Comstock JA, Landwehr DM, et al: Prospective study of microbial colonization of the nose and skin and infection of the vascular access site in hemodialysis patients. J Clin Microbiol 26:1257-1262, 1988
27. Saad TF: Bacteremia associated with tunneled, cuffed hemodialysis catheters. Am J Kidney Dis 34:1114-1124, 1999
28. Beathard GA: Management of bacteremia associated with tunneled-cuffed hemodialysis catheters. J Am Soc Nephrol 10:1045-1049, 1999
29. Hung KY, Tsai TJ, Yen CJ, et al: Infection associated with double lumen catheterization for temporary haemodialysis: experience of 168 cases. Nephrol Dial Transplant 10:247-251, 1995
30. Marr KA, Sexton DJ, Conlon PJ, et al: Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis. Ann Intern Med 127:275-280, 1997
31. Schwab SJ, Buller GL, McCann RL, et al: Prospective evaluation of a Dacron cuffed hemodialysis catheter for prolonged use. Am J Kidney Dis 11:166-169, 1988
32. Moss AH, Vasilakis C, Holley JL, et al: Use of a silicone dual-lumen catheter with a Dacron cuff as a long-term vascular access for hemodialysis patients. Am J Kidney Dis 16:211-215, 1990
33. Tanriover B, Carlton D, Saddekni S, et al: Bacteremia associated with tunneled dialysis catheters: comparison of two treatment strategies. Kidney Int 57:2151-2155, 2000
34. Saad TF: Central venous dialysis catheters: catheter-associated infection. Semin Dial 14:446-451, 2001
35. Ryan SV, Calligaro KD, Scharff J, et al: Management of infected prosthetic dialysis arteriovenous grafts. J Vasc Surg (in press).
36. Palestro CJ, Vega A, Kim CK, et al: Indium-111-labeled leukocyte scintigraphy in hemodialysis access-site infection. J Nucl Med 31:319-324, 1990
37. Stevenson KB, Adcox MJ, Mallea MC, et al: Standardized surveillance of hemodialysis vascular access infections: 18-month experience at an outpatient, multifacility hemodialysis center. Infect Control Hosp Epidemiol 21:200-203, 2000
38. Fong IW, Capellan JM, Simbul M, et al: Infection of arterio-venous fistulas created for chronic haemodialysis. Scand J Infect Dis 25:215-220, 1993
39. Calligaro KD, Veith FJ: Selective prosthetic graft preservation, in Calligaro KD, Veith FJ (eds): Management of Infected Arterial Grafts. St Louis, MO, Quality Medical Publishing, Inc, 1994, pp 202-211
40. Calligaro KD, Veith FJ, Dougherty MJ, et al: Management and outcome of infrapopliteal arterial graft infections with distal graft involvement. Am J Surg 172:178-180, 1996
41. Calligaro KD, Veith FJ, Gupta SK, et al: A modified method for management of prosthetic graft infections involving an anastomosis to the common femoral artery. J Vasc Surg 11:485-492, 1990
42. Calligaro KD, Veith FJ, Valladares JA, et al: Prosthetic patch remnants to treat infected arterial grafts. J Vasc Surg 31:245-252, 2000